From October 6 to 8, 2026, CPHI Milan, a highly influential professional event in the global pharmaceutical ingredients field, was held in Italy. Topscience Biotech showcased products including Pharmaceutical Grade Sodium Hyaluronate, Medical Device Grade Sodium Hyaluronate, Medical Device Grade Chondroitin Sulfate Sodium, and PDRN & PN at the exhibition.

Over the three-day exhibition, Topscience Biotech’s booth saw a continuous stream of visitors: pharmaceutical companies and medical device manufacturers from around the world came one after another. This exhibition was not only a window for product display, but also a frontline dialogue platform for Topscience Biotech to get closer to the European market and listen to customers’ real needs.

The core product portfolio exhibited by Topscience Biotech precisely addressed global pharmaceutical customers’ deeper demands for “high quality, compliance, and stable supply.” Among them, Pharmaceutical Grade Sodium Hyaluronate and Medical Device Grade Chondroitin Sulfate Sodium became the focus of attention on site; Medical Device Grade Sodium Hyaluronate and PDRN & PN also attracted customers from many countries, who held in-depth discussions on product parameters, specification requirements, and customized services.

1. Pharmaceutical Grade Sodium Hyaluronate — its bacterial endotoxins control level was a technical highlight that drew much attention at the exhibition, and can be controlled to ≤0.001 IU/mg. In addition, relying on microbial fermentation technology, the product can achieve precise molecular weight customization, with extremely low impurity levels and strict control of metal residues. Topscience Biotech’s Pharmaceutical Grade Sodium Hyaluronate has completed API compliance registrations in multiple regions worldwide, providing stable and reliable raw material quality support for joint surgery fillers, eye drops, and other formulation projects of leading pharmaceutical companies in the industry.

2. Medical Device Grade Chondroitin Sulfate Sodium — this product is extracted from shark cartilage and uses a proprietary self-developed enzymatic hydrolysis process, with purity as high as 98%, protein content controlled below 0.1%, and extremely low levels of impurities such as endotoxins. It has currently completed Master File registration, making Topscience Biotech the first raw material company in China to have a Master File registration for Medical Device Grade Chondroitin Sulfate Sodium. This product can be widely used in Class II and Class III medical device fields.

CPHI Milan 2026 has come to a successful close. The conclusion is not the end, but another leap forward in Topscience Biotech’s global expansion.

Next stop: CPHI India (November 23–25, 2026, Booth 2B58). We look forward to meeting you there!